Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
Authors:
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 133 (3) , 467-476
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic featuresInternational Clinical Psychopharmacology, 2009
- Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic FeaturesThe Journal of Clinical Psychiatry, 2008
- An Open Pilot Study of the Combination of Escitalopram and Bupropion-SR for Outpatients with Major Depressive DisorderJournal of Psychiatric Practice, 2008
- The empirical status of melancholia: Implications for psychologyClinical Psychology Review, 2005
- Gender Differences in Severity, Symptomatology and Distribution of Melancholia in Major DepressionPsychopathology, 2003
- The self‐administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services researchArthritis Care & Research, 2003
- Is psychotherapy an effective treatment for melancholia and other severe depressive states?Journal of Affective Disorders, 1999
- Maintenance treatment and psychobiologic correlates of endogenous subtypesJournal of Affective Disorders, 1992
- Outcome with desipramine therapy in subtypes of nonpsychotic major depressionJournal of Affective Disorders, 1985
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960